The nasopharyngeal (NP) microbiota of newborns and infants plays a key role in modulating airway inflammation and respiratory symptoms during viral infections. Premature (PM) birth modifies the early NP environment and is a major risk factor for severe viral respiratory infections. However, it is currently unknown if the NP microbiota of PM infants is altered relative to full-term (FT) individuals. Objectives To characterize the NP microbiota differences in preterm and FT infants during rhinovirus (RV) infection. Methods We determined the NP microbiota of infants 6 months to ≤2 years of age born FT (n=6) or severely PM<32 weeks gestation (n=7). We compared microbiota composition in healthy NP samples and performed a longitudinal analysis during naturally occurring RV infections to contrast the microbiota dynamics in PM versus FT infants. Results We observed significant differences in the NP bacterial community of PM versus FT. NP from PM infants had higher within-group dissimilarity (heterogeneity) relative to FT infants. Bacterial composition of NP samples from PM infants showed increased Proteobacteria and decreased in Firmicutes. There were also differences in the major taxonomic groups identified, including Streptococcus, Moraxella, and Haemophilus. Longitudinal data showed that these prematurityrelated microbiota features persisted during RV infection. Conclusions PM is associated with NP microbiota changes beyond the neonatal stage. PM infants have an NP microbiota with high heterogeneity relative to FT infants. These prematurity-related microbiota features persisted during RV infection, suggesting that the NP microbiota of PM may play an important role in modulating airway inflammatory and immune responses in this vulnerable group.
INTRODUCTION
Newborns and infants are obligated nasal breathers; 1 2 thus, the nasopharyngeal (NP) airway is the first line of defense and main port of entry of bacterial and viral respiratory pathogens in early life. This notion has led to the emergent and potentially powerful idea of assessing the NP microbiota of newborns and infants to underpin early-life exposures and host immune responses that determine the initiation and progression of respiratory disorders in humans. [3] [4] [5] [6] [7] [8] Indeed, recent studies have established that the early NP microbial composition correlates with individual nasal cytokine signatures, 3 frequency and severity of upper and lower respiratory infections, [4] [5] [6] [7] [8] as well as subsequent asthma risk. [5] [6] [7] [8] In turn, the infant NP microbiota is a reflection of early exposures (eg, breastfeeding, antibiotics, viral infections, daycare, etc), which critically shape bacterial composition and airway responses against respiratory viruses. What are the new findings?
▸ Infants born prematurely have distinct NP microbiota signatures. ▸ Premature infants have an NP microbiota with high within-group dissimilarity (heterogeneity) relative to full-term age-matched controls. ▸ Prematurity-related microbiota features persisted during rhinovirus infection.
How might these results change the focus of research or clinical practice?
▸ The NP microbiota of newborns and infants plays a key role in modulating airway inflammation and respiratory symptoms during viral infections. Given that viral respiratory infections are the most common cause of hospitalization and death in premature infants, identifying the microbiome changes in this population could lead to therapeutic strategies to improve respiratory outcomes in this vulnerable population. The NP airway of infants born severely premature (PM) undergoes dramatically different early-life exposures in the neonatal intensive care unit (NICU). Prematurity-related challenges include nosocomial pathogens, supplemental oxygen, mechanical respiratory support, broad-spectrum antimicrobials and deprivation of the normal intrauterine environment. We have shown that, beyond the NICU stage, severely PM infants born <32 weeks gestational age (GA) have persistent abnormal nasal airway immune responses against respiratory viruses during the first 2 years of life; 9 10 however, it is unknown if the NP microbiota of PM infants is also persistently different during early childhood relative to infants born at term.
Original research
In this study, we contrasted the NP microbiota of infants 6 months to ≤2 years of age born full term (FT) or severely PM. We compared the microbial composition in healthy NP samples and performed an analysis during naturally occurring rhinovirus (RV) infections to contrast the microbiome dynamics in PM versus FT infants. Our hypothesis was that prematurity leads to a distinct microbiome with unique bacterial composition and this distinct microbiota difference is maintained during viral infections, which are known to change the microbiome composition. The impact of this work is that it presents, for the first time, to the best of our knowledge, a potentially modifiable environmental factor ( prematurity-related NP microbiome) that may contribute to the previously described abnormal nasal airway immune responses and high risk for severe viral respiratory infections in PM infants during their first 2 years of life. 9 10 This new knowledge may ultimately lead to novel approaches to predict and prevent potentially lifethreatening respiratory complications in this vulnerable population.
MATERIALS AND METHODS Study population and nasal sampling
Two nasal washes (W1 and W2) were collected from children aged 6 months to ≤2 years enrolled in the Viral Immuno-genetic Responses of the Airways and the Lungs (VIRAL) cohort at Children's National Medical System. [9] [10] [11] [12] The VIRAL cohort is a longitudinal study of children admitted to the hospital with suspected viral respiratory infections. W1 was taken during acute RV infection as confirmed by PCR. W2 was obtained at follow-up during the study period (1-3 months after the initial sample). W2 was negative for RV and other viruses as confirmed by respiratory virus PCR analysis used for clinical purposes. For paired samples (n=6), we included age-matched and gestational (for preterm subjects) age-matched children born at FT, defined as >37 weeks GA (n=3), or born severely PM, defined as <32 weeks GA (n=3). We also included seven additional subjects (four born FT and three born PM) in which only one time point was available. Table 1 shows all subjects included (n=13) and their baseline characteristics. We used a standard nasal lavage technique consisting of gently washing the nasal cavity with 3-4 mL sterile normal saline as previously described. [9] [10] [11] [12] Exclusion criteria included mixed viral infection or antibiotic therapy <4 weeks prior to microbiome analysis. This study was approved by the Institutional Review Board of Children's National Health System, Washington, DC.
16S ribosomal RNA PCR and next-generation sequencing
Amplification of bacterial 16S ribosomal RNA (rRNA) was performed as previously described by our group. 13 Briefly, the 16S small rRNA subunit was amplified using 'universal' primers (B27F, 5=-AGAGTTTGATCCTGGCTCAG-3=; and U1492R, 5=-GGTTACCTTGTTACGACTT-3=) with Escherichia coli 16S for numbering and a predicted product of 1466 bp. ABI 2700 thermocycler was used for amplifications with a hot-start AmpliTaq Gold 360 DNA polymerase master mix with GC enhancer (Life Technologies). An optimal loading concentration of 500 ng of gDNA was used for most samples (several amplified well with 100-250 ng). After PCR was performed, the presence of amplimers at the expected 1466 bp size was confirmed by gel electrophoresis on a 1% agarose gel stained with ethidium bromide and Agilent 2100 bioanalyzer (Agilent Technologies). PCR products were purified with Agencourt AMPure XP magnetic beads (Beckman-Coulter) and then quantified with an optical density at 260 or 280 nm (OD 260/280 ; NanoDrop) and fluorescence staining (Qubit). Amplimers were pooled if insufficient samples were identified; samples without detectable amplimers were excluded from the analysis. Next-generation sequencing studies were conducted as per published protocols, 13 using purified 16S amplimers (200 to 750 ng) prepared for long-read singlemolecule sequencing (Pacific Biosystems) with a DNA Prep kit 2.0 (250 to <3 kb) followed by standard sequencing primer/polymerase steps (PacBio RS II platform and P4/C2 chemistry). Sequencing data were generated in PacBio native bas.h5 and standard FastQ formats.
Analytical methods
Raw FASTQ files were analyzed in mothur V.1.35.1 using pipelines previously described. 14 15 Briefly, sequences were aligned to the SILVA_V.123 bacterial reference alignment at http://www.mothur.org. Chimeras were excluded by uchime 16 and non-chimeric sequences classified according to naïve Bayesian classifiers. 17 Operational taxonomic units (OTUs) clustering used a 0.03 threshold (species level). OTU sequence representatives and taxonomy were imported (BIOM format) into QIIME 18 for subsequent analyses. The mothur OTU table was filtered (minimum of 2 sequences per OTU) and subsampled (rarefaction analysis, smallest sample size=1037 sequences) to eliminate sample size bias on community composition. OTU differential abundance tests 19 and DESeq2 negative binomial Wald test 20 were also applied for comparison. Trees for phylogenetic diversity were built using FastTree. 21 Taxonomic α-diversity was assessed as the number of observed OTUs, and by the Chao1 and Shannon indexes; phylogenetic α-diversity was determined by Faith's index. 22 Taxonomic (Bray-Curtis and Euclidean) and phylogenetic (unweighted and weighted unifrac) β-diversity metrics were compared between pairs of samples. Procrustes analysis contrasting principal coordinates analysis (PCoA) plots (weighted unifrac distances) of seven paired samples 23 was performed with 10,000 Monte Carlo iterations. The α-diversity and β-diversity metrics were contrasted between and within groups using a non-parametric version of the t-test. Taxonomic and phylogenetic distances were compared among groups using the non-parametric PERMANOVA and adonis tests from the vegan R's library. 24 Significance was determined through 10,000 permutations. Finally, OTU abundance differences between sample pairs were assessed using Fisher's exact test, while OTU abundance differences between sample groups were estimated using rarefied (analysis of variance, Kruskal-Wallis and Welch's t-test) and non-rarefied (metagenomeSeq zero-inflated Gaussian and DESeq2 negative binomial Wald test) tests. Bonferroni or Benjamini-Hochberg false discovery rate (FDR) multiple test correction methods were applied. All analyses were performed in mothur, QIIME, STAMP 25 and RStudio. 26 
RESULTS
A total of 19 nasal microbiomes corresponding to 13 children (6 paired samples and 7 single samples) were analyzed figure 1) . The taxonomic profile of the FT group showed a predominance of Streptococcus (green-brown in figure 1) ; other genera were present in FT during RV infection including Moraxella, Staphylococcus, Burkholderia and Haemophilus. As shown in figure 1 , the group of PM infants had a heterogeneous taxonomic profile with a predominance of Moraxella (light blue) and Burkholderia (light green) mixed with Streptococcus, Neisseria, Staphylococcus, Janthinobacterium, and Haemophilus. In FT and PM, Haemophilus (dark purple) was mostly present during RV infection and it was overall more abundant in the PM group (figure 1). Ordination analysis (PCoA- figure 2A ) revealed within-group dissimilarities between FT and PM NP microbiomes. PCoA clustered FT subjects without viral infection (figure 2 red squares within ellipse) but not PM individuals due to high heterogeneity within the PM group (figure 2 scattered blue dots). These visual dissimilarities were then confirmed by the PERMANOVA and adonis tests, which showed significant differences ( p<0.05) in community composition only between FT and PM (using Bray-Curtis and weighted unifrac distances). All the other comparisons resulted no significance including PCoA according to RV status.
Significant differences ( p<0.05) in OTU abundance (rarefied-based and non-rarefied-based performed tests) were observed between different groups after FDR correction, including an increase in Proteobacteria and decrease in Firmicutes in the PM relative to the FT group ( figure 3A) . Similarly, we also detected significant differences in OTU abundance (Fisher's exact test) between all of the six paired samples (after FDR correction; figure 3B ). These differences in community composition were also manifested in the Procrustes analysis comparing the PCoA plots of microbiomes from paired samples (figure 4), which showed a great dissimilarity between pairs (M 2 =0.704; p<0.001). Notably, the dissimilarity between pairs, represented as the linear distance between healthy and RV samples in PCoA plots, was greater in the PM relative to the FT group (figure 4). We did not detect significant differences in α-diversity (observed OTUs, Chao1, Shannon and Faith) between any of the groups compared. Nonetheless, FT showed overall greater mean diversity than PT for all four indexes compared, while RV and non-virus comparison showed more similar estimates for the same indexes (data not shown).
DISCUSSION
The NP microbiota of newborns and infants plays a key role in modulating airway inflammation and respiratory symptoms during viral infections. 8 We have shown that severely PM infants (<32 weeks GA) have abnormal nasal airway immune responses against viruses, 9 10 but it is unknown if the NP microbiota of PM infants differs from that seen in FT individuals and if this difference is maintained during viral infections. Filling this important gap, in this study we found that PM infants have an NP microbiota with high within-group dissimilarity (heterogeneity) relative to FT age-matched controls. Also, our data suggest that the microbiota in PM infants is less resilient during RV infection (figure 4), suggesting that the NP microbiota of PM infants may play an important role in modulating airway inflammatory and immune responses in this vulnerable group.
There is increasing evidence demonstrating that PM infants have widespread defects in innate immunity that facilitate the inception of infections caused by bacteria, viruses and other microorganisms. 27 28 In addition, prematurity appears to be associated with an immune dysregulated state characterized by abnormal secretion of proinflammatory cytokines in response to different environmental stressors. 29 30 The abnormal immune responses and enhanced inflammatory responses of prematurity generate a unique host environment, which, in combination with early nosocomial exposures, results in distinct microbial communities colonizing different systems. 31 32 An example is the increasingly clear link between the abnormal gut microbiota composition in PM infants and the development of necrotizing enterocolitis. 32 In addition, abnormalities in the airway microbiome diversity of PM infants have also been described in association with the development of bronchopulmonary dysplasia (BPD), 31 the most common chronic respiratory complication in this vulnerable population. Our current study adds another layer of complexity to the previously described abnormalities in the microbiota of PM infants, identifying significant differences in the NP microbiota of severe preterm children after NICU discharge relative to FT controls, difference that is maintained during RV infection, which is known to change the microbiota composition. 7 8 These findings suggest that the PM airway microbiota is altered at baseline and can be disrupted further by relatively minor environmental challenges, such as viral illnesses.
Our taxonomic results of NP microbiota are consistent with previous data reported in infants and children. 3 8 In a recent study, Teo et al 8 demonstrated that the NP microbiome of infants has a simple structure dominated by six clusters: Streptococcus, Moraxella, Staphylococcus, Haemophilus, Corynebacterium and Alloiococcus (genus Dolosigranulum in some databases). 8 In our study, we found NP dominance of Streptococcus and Moraxella with a scattered presence of Staphylococcus and Haemophilus. We did not identify children with NP dominance of Figure 2 PCoA of seasonal groups (Bray-Curtis distances). These plots show dissimilarities or similarities between groups. PCoA clustered full-term subjects without viral infection (red squares within ellipse). FT, full term; PCoA, principal coordinates analysis; PM, premature.
Corynebacterium or Alloiococcus, likely because these two clusters are associated with healthy children without a history of respiratory infections; 7 8 in our sample, all FT subjects had a history of RV infection. Interestingly, we found that while FT infants had NP dominance of Streptococcus (green-brown in figure 1) , PM infants had a highly heterogeneous microbiota with less Streptococcus and emergence of a mixed flora including Moraxella (light blue in figure 1 ) and other Gram-negative bacteria (eg, Burkholderia, Neisseria and Janthinobacterium). At the phylum level, PM infants showed increased Proteobacteria (major group of Gram-negative bacteria) and decreased Firmicute (Gram-positive bacteria such as Clostridium and Lactobacillus), which is an airway microbiome signature recently described in PM newborns, particularly in those with increased BPD risk. 31 The most striking feature identified in the NP microbiota of PM infants was the presence of within-group dissimilarity (high heterogeneity), suggesting that this group does not develop a stable NP microbiome in early life. In this context, it is noteworthy that recent longitudinal studies [6] [7] [8] have demonstrated that by 2 months of age most humans develop a stable NP microbiota with low intrasubject variability and dominance of specific genera. 8 Interestingly, the individual NP microbiome predominance reflects environmental exposures (eg, antibiotics, daycare, siblings, etc), [6] [7] [8] and predicts subsequent risk to develop respiratory conditions including viral respiratory infections, pneumonia and asthma. [3] [4] [5] [6] [7] [8] Specifically, while NP microbiota dominated by Corynebacterium or Alloiococcus clusters is linked to less respiratory morbidity, 7 8 early NP colonization with Streptococcus, Moraxella or Haemophilus is associated with an increased risk for pneumonia or bronchiolitis in early childhood. [3] [4] [5] [6] [7] [8] We speculate that the presence of multiple environmental challenges may prevent or delay the establishment of a stable NP microbiome in PM infants, which may play a pivotal role in the generation of prematurity-related acute and longterm respiratory complications. One of the most important environmental factors that shape the NP microbiota of infants is the presence of viral respiratory infections. Prior studies have established that RV and respiratory syncytial virus increase the abundance of Streptococcus, Moraxella and Haemophilus. 7 8 33 Teo et al 8 have shown that Haemophilus is rarely found in healthy NP samples of infants, but is common during and shortly after acute viral respiratory infections. In our study, we found distinct microbiota during RV infection in infants with major differences seen in the abundance of Haemophilus and Moraxella, particularly in the PM group ( figure 3) . Notably, the high within-group dissimilarity seen in the NP microbiome of PM infants was augmented during RV infection (figure 4), further supporting the concept that prematurity may lead to an 'unstable' NP microbiome in early childhood, predisposing to widespread changes in bacterial diversity changes during relatively minor ecological perturbations (viral illnesses). This may have significant pathogenic consequences because exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection. 34 A limitation of this study is that the first set of samples was obtained during a viral infection and the second set after recovery and viral clearance (negative PCR); thus, we cannot establish the baseline (prior to infection) microbiota of subjects. Although the Procrustes plot and the paired samples for FT babies are less different, we cannot conclude if this change is only due to prematurity or if it is because these communities are more resilient due to other factors such as the timing of the second sample (eg, ∼1 month). Also, we could argue that FT babies may be more prone to RV since the microbiota has not changed much during and postinfection. Another limitation of our study is the small number of sample size; the microbiota changes described here could vary when more samples are analyzed.
Longitudinal studies are critically needed to further investigate the interplay between PM birth, NP microbiota and the development of airway immune responses against respiratory viruses in early life. Given that viral respiratory infections are the most common cause of hospitalization and death in PM infants, 35 36 these studies may have a significant impact leading to novel diagnostic and therapeutic strategies to improve respiratory outcomes in this vulnerable population. Figure 4 Procrustes analysis of PCoA plots of microbiota with and without RV infection. Nasopharyngeal pair samples collected from the same individual (n=6) are connected by a line that represents dissimilarity between healthy (no virus) and RV infection in the same subject. All pair samples showed dissimilarity (healthy vs RV) but dissimilarities were greater in the premature group. Red=premature; green=full term. PCoA, principal coordinates analysis; RV, rhinovirus.
